Automatic implantable cardioverter-defibrillator: patient survival, battery longevity and shock delivery analysis

The automatic implantable cardioverter-defibrillator (AICD) has been shown to reduce the mortality rate of patients with malignant ventricular tachyarrhythmias. This report describes experience with implantation of 36 automatic implantable cardioverter-defibrillators (AID-B and AID-BR models) in 22 persons over a 44 month patient follow-up period (mean 19.6 months). There were five deaths: two patients died suddenly 22 and 29 months, respectively, after their second implant, one died of congestive heart failure, one died of respiratory failure and one died of catheter sepsis. Although 11 (50%) of the 22 patients never received a countershock for a ventricular tachyarrhythmia and are still alive, the other 11 received one or more spontaneous countershocks. Nine patients (41%) experienced spurious shocks during the follow-up period. Assuming that the first shock for presumed ventricular tachyarrhythmia prevented death, the hypothetical cumulative survival of patients at 42 months would have been 34 +/- 14.1% in the absence of an automatic implantable cardioverter defibrillator rather than the actual survival rate of 59 +/- 16.8%. The cumulative device survival of the 36 AID-B units was 92 +/- 5.62% at 15 months but diminished to 37 +/- 14.4% by 20 months. No unit lasted longer than 22 months. There were 12 battery depletions. The number of shocks emitted did not influence unit longevity. The manufacturer's elective replacement indicator is of uncertain validity. Six units remained active 7 to 17 months after surpassing their replacement indicator. The automatic implantable cardioverter-defibrillator prolongs the life of many patients with otherwise intractable arrhythmias.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S.-C. Seow, C. S. Tolentino, J. Zhao, and T.-W. Lim Azygous vein coil lowers defibrillation threshold in patients with high defibrillation threshold Europace, June 1, 2011; 13(6): 825 - 828. [Abstract] [Full Text] [PDF]

				P. M. McCarthy Ventricular aneurysms, shock, and late follow-up in patients with heart failure J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 323 - 325. [Full Text] [PDF]

				G. D. Sanders, M. A. Hlatky, N. R. Every, K. M. McDonald, P. A. Heidenreich, L. S. Parsons, and D. K. Owens Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction Ann Intern Med, November 20, 2001; 135(10): 870 - 883. [Abstract] [Full Text] [PDF]

				J P Bourke, A Loaiza, G Parry, C Hilton, S Furniss, J Dark, and J Forty Role of orthotopic heart transplantation in the management of patients with recurrent ventricular tachyarrhythmias following myocardial infarction Heart, November 1, 1998; 80(5): 473 - 478. [Abstract] [Full Text]

				Y. Yamanouchi, K. A. Mowrey, M. J. Niebauer, P. J. Tchou, and B. L. Wilkoff Additional Lead Improves Defibrillation Efficacy With an Abdominal `Hot Can' Electrode System Circulation, December 16, 1997; 96(12): 4400 - 4407. [Abstract] [Full Text]

				G. Gioia, B. Bagheri, C. D. Gottlieb, D. S. Schwartzman, D. J. Callans, F. E. Marchlinski, J. Heo, and A. E. Iskandrian Prediction of Outcome of Patients With Life-Threatening Ventricular Arrhythmias Treated With Automatic Implantable Cardioverter-Defibrillators Using SPECT Perfusion Imaging Circulation, January 21, 1997; 95(2): 390 - 394. [Abstract] [Full Text]

				L. A. Robinson, J. R. Windle, and A. R. Easley Options in managing the patient with high defibrillation thresholds Ann. Thorac. Surg., May 1, 1994; 57(5): 1184 - 1192. [Abstract] [PDF]

				T. J. Cohen, P. R. Reid, M. M. Mower, M. Mirowski, D. Aarons, J. Juanteguy, and E. P. Veltri The Automatic Implantable Cardioverter-Defibrillator: Long-term Clinical Experience and Outcome at a Hospital Without an Open-Heart Surgery Program Arch Intern Med, January 1, 1992; 152(1): 65 - 69. [Abstract] [PDF]

				M. Akhtar, H. Garan, M. H. Lehmann, and P. J. Troup Sudden Cardiac Death: Management of High-Risk Patients Ann Intern Med, March 15, 1991; 114(6): 499 - 512. [Abstract] [PDF]

				E. S. Yee Automatic Implantable Cardioverter Defibrillators: Surgical Approaches for Optimal Function Vascular and Endovascular Surgery, November 1, 1989; 23(6): 458 - 463. [Abstract] [PDF]

				S. Saksena, N. G. Tullo, R. B. Krol, and A. M. Mauro Initial Clinical Experience With Endocardial Defibrillation Using an Implantable Cardioverter/Defibrillator With a Triple-Electrode System Arch Intern Med, October 1, 1989; 149(10): 2333 - 2339. [Abstract] [PDF]

				A. S. Manolis, H. Rastegar, and N. A. M. Estes III Automatic Implantable Cardioverter Defibrillator: Current Status JAMA, September 8, 1989; 262(10): 1362 - 1368. [Abstract] [PDF]

				G. F. O. Tyers Reply Ann. Thorac. Surg., March 1, 1989; 47(3): 485 - 485. [PDF]

				P. J. Tchou, N. Kadri, J. Anderson, J. A. Caceres, M. Jazayeri, and M. Akhtar Automatic Implantable Cardioverter Defibrillators and Survival of Patients with Left Ventricular Dysfunction and Malignant Ventricular Arrhythmias Ann Intern Med, October 1, 1988; 109(7): 529 - 534. [Abstract] [PDF]